Discover

RZLT
Rezolute, Inc.
4.87
2 x 3.47
2 x 4.89
bid
ask
+
0.23
4.96%
2 @ 07:54 PM
4.90 +0.03 (0.62%)
Ytd106.36%
1y-44.85%
4.55
day range
4.91
1.40
52 week range
10.94
Open4.60Prev Close4.64Low4.55High4.91Mkt Cap471.04M
Vol1.87MAvg Vol1.50MEPS-0.75P/EN/AForward P/E-3.42
Beta1.19Short Ratio3.16Inst. Own64.24%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0550-d Avg4.46200-d Avg3.751yr Est13.00

RZLT News

Rezolute, Inc. (NASDAQ:RZLT) Stock Now Rated “Moderate Buy” by Sell-Side Analysts
defenseworld.net
Rezolute, Inc. (NASDAQ:RZLT) Stock Now Rated “Moderate Buy” by Sell-Side Analysts

Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) has been assigned an average recommendation of "Mode

This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
benzinga.com
This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Analysts upgraded NetApp, Humana, Corteva, Afya, with price-target changes for four stocks.

benzinga.com
Lake Street Maintains Buy on Rezolute, Raises Price Target to $12

Lake Street analyst Daniel Brims maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the price

benzinga.com
Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $15

Citizens analyst Jason N. Butler maintains Rezolute (NASDAQ:RZLT) with a Market Outperform and ra

This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
benzinga.com
This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded Boyd Gaming, NeoGenomics, PENN Entertainment, XP and Rezolute, raising targets for

FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints
benzinga.com
FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints

Rezolute (NASDAQ: RZLT) shares surged after the FDA recommended a pre-BLA meeting for its congenital

Rezolute (NASDAQ:RZLT) Stock Sees Unusually High Call Option Buying
defenseworld.net
Rezolute (NASDAQ:RZLT) Stock Sees Unusually High Call Option Buying

Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) was the recipient of some unusual options trading ac

benzinga.com
Rezolute Gets FDA Recommendation For Pre-BLA Meeting Ahead Of Ersodetug BLA Submission For Congenita

The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tu

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
globenewswire.com
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biolo

The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tu

Why Vicor Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Vicor Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Vicor shares surged 12% after raising Q3 growth guidance above 30%; Roze AI led gainers, while Corte

benzinga.com
Lake Street Initiates Coverage On Rezolute with Buy Rating, Announces Price Target of $9

Lake Street analyst Daniel Brims initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating a

This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
benzinga.com
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target

benzinga.com
Craig-Hallum Upgrades Rezolute to Buy, Raises Price Target to $7

Craig-Hallum analyst Albert Lowe upgrades Rezolute (NASDAQ:RZLT) from Hold to Buy and raises the

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
benzinga.com
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

U.S. stocks rose as oil fell on Strait of Hormuz hopes; Benzinga highlights top analysts’ picks: OKT

benzinga.com
HC Wainwright & Co. Maintains Buy on Rezolute, Raises Price Target to $10

HC Wainwright & Co. analyst Douglas Tsao maintains Rezolute (NASDAQ:RZLT) with a Buy and rais

benzinga.com
Rezolute Q4 EPS $(0.20) Misses $(0.15) Estimate

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.20) per share which missed the analyst conse

Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
globenewswire.com
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Up

REDWOOD CITY, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

Rezolute, Inc. (NASDAQ:RZLT) Receives $9.38 Average Price Target from Analysts
defenseworld.net
Rezolute, Inc. (NASDAQ:RZLT) Receives $9.38 Average Price Target from Analysts

Shares of Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) have earned a consensus recommendation of

benzinga.com
Rezolute Said FDA Is Still Reviewing Ersodetug Submission In Congenital Hyperinsulinism; The Company

Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoin

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
globenewswire.com
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsul

Data from the Phase 3 sunRIZE study remains under review by FDA  The OLE Phase of the study is ongoi

Rezolute to Participate in Upcoming Investor Conferences
globenewswire.com
Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o

Rezolute, Inc. $RZLT Shares Sold by Bank of America Corp DE
defenseworld.net
Rezolute, Inc. $RZLT Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Rezolute, Inc. (NASDAQ: RZLT) by 31.3% during the undef

MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday
benzinga.com
MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w

Rezolute to Participate in the BTIG Virtual Biotechnology Conference
globenewswire.com
Rezolute to Participate in the BTIG Virtual Biotechnology Conference

REDWOOD CITY, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
globenewswire.com
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinic

Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis

RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?
zacks.com
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?

Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
globenewswire.com
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
benzinga.com
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stock

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study
benzinga.com
Rezolute Highlights Strong Early Response Trends In Rare Hypoglycemia Disease Study

Rezolute, Inc. (NASDAQ:RZLT) reported an interim update from its ongoing Phase 3 upLIFT study evalua

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
globenewswire.com
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperins

Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study's

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
globenewswire.com
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute to Participate in Upcoming Investor Conferences
globenewswire.com
Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
globenewswire.com
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patie

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat

Rezolute, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
Rezolute, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rezolute, Inc., (“Rezol

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
globenewswire.com
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pedi

Oral presentation will include previously announced topline results as well as pre-specified and pos

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
zacks.com
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earli

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Sess

benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday, 125 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 111 stocks hit new 52-week lows.